Literature DB >> 8325646

Refined assignment of the infantile neuronal ceroid lipofuscinosis (INCL, CLN1) locus at 1p32: incorporation of linkage disequilibrium in multipoint analysis.

E Hellsten1, J Vesa, M C Speer, T P Mäkelä, I Järvelä, K Alitalo, J Ott, L Peltonen.   

Abstract

Infantile neuronal ceroid lipofuscinosis, INCL, CLN1, is an autosomally inherited progressive neurogenerative disorder. The disease results in the massive death of cortical neurons, suggesting an essential role for the CLN1 gene product in the normal neuronal maturation during the first years of life. Identification of new multiallelic markers has now made possible the construction of a refined genetic map encompassing the CLN1 locus at 1p32. Strong allelic association was detected with a new, highly polymorphic HY-TM1 marker. We incorporated this observed linkage disequilibrium into multipoint linkage analysis, which significantly increased the informativeness of the limited family material and facilitated refined assignment of the CLN1 locus.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8325646     DOI: 10.1006/geno.1993.1253

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  24 in total

1.  Linkage analysis in the presence of errors IV: joint pseudomarker analysis of linkage and/or linkage disequilibrium on a mixture of pedigrees and singletons when the mode of inheritance cannot be accurately specified.

Authors:  H H Göring; J D Terwilliger
Journal:  Am J Hum Genet       Date:  2000-03-23       Impact factor: 11.025

2.  Linkage analysis in the presence of errors III: marker loci and their map as nuisance parameters.

Authors:  H H Göring; J D Terwilliger
Journal:  Am J Hum Genet       Date:  2000-03-23       Impact factor: 11.025

3.  Expression and activity of L-Myc in normal mouse development.

Authors:  K S Hatton; K Mahon; L Chin; F C Chiu; H W Lee; D Peng; S D Morgenbesser; J Horner; R A DePinho
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

4.  Linkage disequilibrium mapping in isolated populations: the example of Finland revisited.

Authors:  A de la Chapelle; F A Wright
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

5.  The age of human mutation: genealogical and linkage disequilibrium analysis of the CLN5 mutation in the Finnish population.

Authors:  T Varilo; M Savukoski; R Norio; P Santavuori; L Peltonen; I Järvelä
Journal:  Am J Hum Genet       Date:  1996-03       Impact factor: 11.025

6.  PSEUDOMARKER: a powerful program for joint linkage and/or linkage disequilibrium analysis on mixtures of singletons and related individuals.

Authors:  Tero Hiekkalinna; Alejandro A Schäffer; Brian Lambert; Petri Norrgrann; Harald H H Göring; Joseph D Terwilliger
Journal:  Hum Hered       Date:  2011-07-28       Impact factor: 0.444

7.  On the statistical properties of family-based association tests in datasets containing both pedigrees and unrelated case-control samples.

Authors:  Tero Hiekkalinna; Harald H H Göring; Brian Lambert; Kenneth M Weiss; Petri Norrgrann; Alejandro A Schäffer; Joseph D Terwilliger
Journal:  Eur J Hum Genet       Date:  2011-09-21       Impact factor: 4.246

8.  Lipid thioesters derived from acylated proteins accumulate in infantile neuronal ceroid lipofuscinosis: correction of the defect in lymphoblasts by recombinant palmitoyl-protein thioesterase.

Authors:  J Y Lu; L A Verkruyse; S L Hofmann
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

9.  Assignment of the locus for a new lethal neonatal metabolic syndrome to 2q33-37.

Authors:  I Visapää; V Fellman; T Varilo; A Palotie; K O Raivio; L Peltonen
Journal:  Am J Hum Genet       Date:  1998-11       Impact factor: 11.025

10.  The genetic locus for free sialic acid storage disease maps to the long arm of chromosome 6.

Authors:  L Haataja; J Schleutker; A P Laine; M Renlund; M L Savontaus; C Dib; J Weissenbach; L Peltonen; P Aula
Journal:  Am J Hum Genet       Date:  1994-06       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.